Evidence map›Paper›PMID 18028537›Full record

ArticleTrials2007

Marketing and clinical trials: a case study.

David Francis, Ian Roberts, Diana R Elbourne, Haleema Shakur, Rosemary C Knight, Jo Garcia, Claire Snowdon, Vikki A Entwistle, Alison M McDonald, Adrian M Grant and 1 more

Abstract read
In one paragraph

Article in Trials, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Strategies to improve retention in randomised trials.The Cochrane database of systematic reviews · 2013
    Pooled it
  2. Pooled it
  3. Trial
  4. Interventions to increase enrollment in a large multicenter phase 3 trial of carotid stenting vs. endarterectomy.International journal of stroke : official journal of the International Stroke Society · 2012
    Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David FrancisCentre for Research and Innovation Management, Brighton, UK. dlf@brighton.ac.uk
Ian Roberts
Diana R Elbourne
Haleema Shakur
Rosemary C Knight
Jo Garcia
Claire Snowdon
Vikki A Entwistle
Alison M McDonald
Adrian M Grant
Marion K Campbell

Funding

Chief Scientist Office HSRU1Medical Research Council MC_U122797165
6 · The paper itself

Abstract

backgroundPublicly funded clinical trials require a substantial commitment of time and money. To ensure that sufficient numbers of patients are recruited it is essential that they address important questions in a rigorous manner and are managed well, adopting effective marketing strategies.

methodsUsing methods of analysis drawn from management studies, this paper presents a structured assessment framework or reference model, derived from a case analysis of the MRC's CRASH trial, of 12 factors that may affect the success of the marketing and sales activities associated with clinical trials.

resultsThe case study demonstrates that trials need various categories of people to buy in - hence, to be successful, trialists must embrace marketing strategies to some extent.

conclusionThe performance of future clinical trials could be enhanced if trialists routinely considered these factors.

Identifiers

PMID18028537
PMCPMC2212650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.